March 15, 2017
Wellesley, Mass., Mar 15, 2017 – New proprietary research by BCC Research predicts that new and innovative antifungal drugs in development, along with a growing number of people with weakened immune systems and FDA fast-track provisions, are aiding growth in the global market for antifungal drugs.
BCC Research's Antifungal Drugs: Technologies and Global Markets expects the global market for antifungal drugs to reach $16.1 billion in 2021, up from $13.1 billion in 2016.
"While the North American market remains the largest geographic region by value, the Asia-Pacific region is the driver of the global market," says BCC Research Editorial Director Kevin Fitzgerald. "BCC Research predicts that region and North America to account for 24.9% and 36.9% of the global market in 2021, respectively."
Innovative Products in Development Pipeline
Although no new antifungal drug classes have emerged, many products are under development, including VL-2397, a novel antifungal drug initially developed by Vical Incorporated partner, Astellas Pharma; PC945, a novel triazole anti-fungal (inhaled treatment) for pulmonary aspergillosis; and CD101 IV, a novel molecule of antifungals for the treatment of systemic Candida infections.
"A lack of funding and development of new and innovative antifungal drug classes has restrained the market," says Fitzgerald. “In the last 30 years, only one new class of antifungal drugs, echinocandins, has been developed. Whatever the reason for this paucity, the need for new, improved, and affordable antifungal treatments with greater safety and efficacy is clear."
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at email@example.com.
Antifungal Drugs: Technologies and Global Markets( PHM029F )
Publish Date: Mar 2017
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email firstname.lastname@example.org or visit www.bccresearch.com/media to request access to our library of market research.